SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System

Go back to SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System
SCHERING-PLOUGH CORPORATION (NASDAQ: SGP) Delayed: 28.07 +0.36 (1.30%)
Previous Close $27.71    52 Week High $29.75 
Open $27.43    52 Week Low $15.27 
Day High $28.30    P/E 18.59 
Day Low $27.33    EPS $1.51 
Volume 66,896